12.03
+0.01
(0.08%)
May 21 - Close
SHA
real-time data -
Disclaimer
Currency in CNY
| Range | 11.80 - 12.07 |
| 52 week | 8.83 - 12.90 |
| Open | 12.03 |
| Vol. | 20.65M |
| Mkt cap | 22.91B |
| P/E | 15.50 |
| EPS | 0.78 |
| Shares | 1.90B |
Events
Jun 28, 2013
Shanghai Fosun Pharmaceutical Group Co Ltd Annual Shareholder Meeting
- 9:00AM GMT+8 -
May 20, 2013
Shanghai Fosun Pharmaceutical Group Co Ltd at Deutsche Bank dbAccess Asia Conference
May 17, 2013
复星医药：关于选举职工监事的公告
May 13, 2013
复星医药：关于召开2012年度股东大会的通知公告
May 13, 2013
复星医药：2012年度股东大会会议资料
May 13, 2013
复星医药：2011年公司债券(第一期)受托管理事务报告(2012年度)
May 7, 2013
复星医药：H股公告
May 7, 2013
复星医药：关于�11复星债�2012年跟踪评级结果的公告
May 7, 2013
复星医药：2011年公司债券(第一期)跟踪评级报告
Apr 27, 2013
复星医药：收购资产公告
|
|
Key stats and ratios
| Q1 (Mar '13) | 2012 | |
| Net profit margin | 20.06% | 25.06% |
| Operating margin | 21.23% | 27.74% |
| EBITD margin | - | 1.85% |
| Return on average assets | 6.43% | 7.70% |
| Return on average equity | 10.27% | 13.41% |
| Employees | 14,357 | - |
| Carbon Disclosure Rating | - | - |
Address
Fosun Commercial Building No. 2 Fuxing East Road
SHANGHAI, SHA 200010
China
+86-21-23138000 (Phone)
+86-21-23138052 (Fax)
SHANGHAI, SHA 200010
China
+86-21-23138000 (Phone)
+86-21-23138052 (Fax)
Website links
External links
Discussion Group - Google Finance
Advertisement
Description
Shanghai Fosun Pharmaceutical (Group) Co., Ltd is a China-based company engaged in research, development, production and sale of medical products. The Company's products are mainly used in the treatment of metabolism and digestive tract system, cardiovascular system, central nervous system, blood system and anti-infection diseases. Its products include Atomolan, MoluoDan and Composite Aloe, among others. The Company also involves in drug distribution and retail, medical equipment and medical diagnosis business, as well as the provision of medical services. It distributes its products primarily in domestic and overseas markets.
Officers and directors
| Qiyu Chen | Chairman of the Board, Executive Director | |
| Fang Yao | Vice Chairman of the Board, President, Executive Director | |
| Zhicheng Qiao | Chief Financial Officer, Senior Vice President, Secretary of the Board | |
| Chun Li | Senior Vice President | |
| Dongjiu Li | Senior Vice President | |
| Xianlin Li | Senior Vice President | |
| Cheng Wang | Senior Vice President | |
| Xinmin Zhang | Senior Vice President | |
| Zhiping Cui | Vice President | |
| Xiaojun Ding | Vice President |